Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex

Conditions:   Facial Angiofibroma;   Tuberous Sclerosis Interventions:   Drug: rapamycin;   Drug: placebo Sponsor:   Dermatology Specialties Limited Partnership Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials